Research Posts on Medivizor
Navigation Menu

Research Posts on Medivizor

Arginine and erectile dysfunction

Posted by on Feb 20, 2019 in Erectile dysfunction | 0 comments

In a nutshell This study looked at the safety and effectiveness of arginine in the treatment of erectile dysfunction (ED). It concluded that arginine is safe and effective in treating mild or moderate ED.  Some background ED is when you cannot get or keep an erection firm enough to have intercourse. ED can occur from a physical...

Read More

Risk of blood clots in breast cancer patients treated with aromatase inhibitors or tamoxifen

Posted by on Feb 20, 2019 in Breast cancer | 0 comments

In a nutshell This study wanted to find out if the risk of patients with breast cancer developing a blood clot was higher if they were treated with aromatase inhibitors, or tamoxifen (Nolvadex). The study found that the patients treated with tamoxifen had a higher risk of developing blood clots compared to those treated with aromatase...

Read More

Safety and effectiveness of urinary slings for stress urinary incontinence

Posted by on Feb 20, 2019 in Urinary incontinence | 0 comments

In a nutshell This study looked at the safety and effectiveness of urinary slings in the treatment of stress urinary incontinence (SUI). It concluded that urinary slings are safe and effective.  Some background Stress incontinence (SUI) is urine leakage when there is pressure on the bladder. It is often observed when a patient coughs,...

Read More

Survival in patients with melanoma treated with pembrolizumab

Posted by on Feb 20, 2019 in Melanoma | 0 comments

In a nutshell This study wanted to find out what the survival rates are of patients with melanoma treated with pembrolizumab (Keytruda). The study found that after 5 years, there was a good response to treatment overall. Some background Pembrolizumab is a new cancer treatment. It treats many different types of cancer. It works by using the immune...

Read More

Kidney problems and anemia linked with imatinib use in chronic myeloid leukemia

Posted by on Feb 20, 2019 in Leukemia | 0 comments

In a nutshell This study looked at the effect of imatinib (Gleevec) on kidney function in patients with chronic myeloid leukemia (CML). Researchers found that a reversible decline in kidney function was linked with long-term imatinib use in these patients. Some background Imatinib is a strong drug used to treat CML. The kidney produces a hormone that...

Read More

Is physical activity a protective factor for lower urinary tract symptoms in male patients?

Posted by on Feb 20, 2019 in Benign prostatic hyperplasia | 0 comments

In a nutshell This study investigated the effect of physical activity on lower urinary tract symptoms (LUTS) in patients with benign prostatic hyperplasia (BPH). This study found that reduced exercise is associated with an increased risk of LUTS.  Some background People diagnosed with BPH (non-cancerous overgrowth of the prostate) often...

Read More

Does bone Hodgkin lymphoma affect survival in patients with Hodgkin lymphoma?

Posted by on Feb 19, 2019 in Hodgkin's lymphoma | 0 comments

In a nutshell This study investigated if patients with Hodgkin lymphoma (HL) found in the bones have worse outcomes than patients with HL in the lymph nodes. It was found that having bone HL did not reduce survival of patients. Some background Many patients with HL are cured by treatment. After 5 years, almost 86% of patients survive. When...

Read More

Allogenic hematopoietic stem cell transplantation as treatment for patients with BCR-ABL1-negative atypical chronic myeloid leukemia

Posted by on Feb 17, 2019 in Leukemia | 0 comments

In a nutshell This study aimed to investigate if allogeneic hematopoietic stem cell transplant is an effective treatment for atypical chronic myeloid leukemia. This study concluded that this treatment is effective in these patients. Some background Atypical chronic myeloid leukemia (aCML) and chronic neutrophilic leukemia (CNL) are cancers...

Read More